2020 ICD-10-CM Diagnosis Code R87.820

Cervical low risk human papillomavirus (HPV) DNA test positive

    2016 2017 2018 2019 2020 Billable/Specific Code
  • R87.820 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Cervical low risk HPV DNA test positive
  • The 2020 edition of ICD-10-CM R87.820 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of R87.820 - other international versions of ICD-10 R87.820 may differ.
The following code(s) above R87.820 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to R87.820:
  • R00-R99
    2020 ICD-10-CM Range R00-R99

    Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

    Note
    • This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
    • Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
    • The conditions and signs or symptoms included in categories R00-R94 consist of:
    • (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
    • (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
    • (c) provisional diagnosis in a patient who failed to return for further investigation or care;
    • (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
    • (e) cases in which a more precise diagnosis was not available for any other reason;
    • (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
    Type 2 Excludes
    • abnormal findings on antenatal screening of mother (O28.-)
    • certain conditions originating in the perinatal period (P04-P96)
    • signs and symptoms classified in the body system chapters
    • signs and symptoms of breast (N63, N64.5)
    Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
  • R83-R89
    2020 ICD-10-CM Range R83-R89

    Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

    Type 1 Excludes
    • abnormal findings on antenatal screening of mother (O28.-)
    • diagnostic abnormal findings classified elsewhere - see Alphabetical Index
    Type 2 Excludes
    • abnormal findings on examination of blood, without diagnosis (R70-R79)
    • abnormal findings on examination of urine, without diagnosis (R80-R82)
    • abnormal tumor markers (R97.-)
    Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
  • R87
    ICD-10-CM Diagnosis Code R87

    Abnormal findings in specimens from female genital organs

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Includes
    • abnormal findings in secretion and smears from cervix uteri
    • abnormal findings in secretion and smears from vagina
    • abnormal findings in secretion and smears from vulva
    Abnormal findings in specimens from female genital organs
  • R87.82
    ICD-10-CM Diagnosis Code R87.82

    Low risk human papillomavirus (HPV) DNA test positive from female genital organs

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Use Additional
    • code for associated human papillomavirus (B97.7)
    Low risk human papillomavirus (HPV) DNA test positive from female genital organs
Approximate Synonyms
  • Cervical low risk human papilloma virus test positive
  • Low risk human papillomavirus deoxyribonucleic acid test positive in specimen from cervix
ICD-10-CM R87.820 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 742 Uterine and adnexa procedures for non-malignancy with cc/mcc
  • 743 Uterine and adnexa procedures for non-malignancy without cc/mcc
  • 760 Menstrual and other female reproductive system disorders with cc/mcc
  • 761 Menstrual and other female reproductive system disorders without cc/mcc

Convert R87.820 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to R87.820:
  • Type 2 Excludes: R87.61
    ICD-10-CM Diagnosis Code R87.61

    Abnormal cytological findings in specimens from cervix uteri

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • abnormal cytological findings in specimens from vagina (R87.62-)
    • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    Type 2 Excludes
    • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
    • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Diagnosis Index entries containing back-references to R87.820:

ICD-10-CM Codes Adjacent To R87.820
R87.625 Unsatisfactory cytologic smear of vagina
R87.628 Other abnormal cytological findings on specimens from vagina
R87.629 Unspecified abnormal cytological findings in specimens from vagina
R87.69 Abnormal cytological findings in specimens from other female genital organs
R87.7 Abnormal histological findings in specimens from female genital organs
R87.8 Other abnormal findings in specimens from female genital organs
R87.81 High risk human papillomavirus (HPV) DNA test positive from female genital organs
R87.810 Cervical high risk human papillomavirus (HPV) DNA test positive
R87.811 Vaginal high risk human papillomavirus (HPV) DNA test positive
R87.82 Low risk human papillomavirus (HPV) DNA test positive from female genital organs
R87.820 Cervical low risk human papillomavirus (HPV) DNA test positive
R87.821 Vaginal low risk human papillomavirus (HPV) DNA test positive
R87.89 Other abnormal findings in specimens from female genital organs
R87.9 Unspecified abnormal finding in specimens from female genital organs
R88 Abnormal findings in other body fluids and substances
R88.0 Cloudy (hemodialysis) (peritoneal) dialysis effluent
R88.8 Abnormal findings in other body fluids and substances
R89 Abnormal findings in specimens from other organs, systems and tissues
R89.0 Abnormal level of enzymes in specimens from other organs, systems and tissues
R89.1 Abnormal level of hormones in specimens from other organs, systems and tissues
R89.2 Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.